Carlo Sansalone
Vermögen: 52 000 $ am 31.08.2026
Vermögen: 52 000 $ am 31.08.2026
Carlo Sansalone is President & Director at Sanscon Construction Ltd. since 1999.
Mr. Sansalone is Independent Director at Pharmather Holdings Ltd. since 2020.
Former roles include Independent Director at Mercury Capital II Ltd., Independent Director at Revive Therapeutics Ltd. from 2014 to 2019, and Independent Non-Executive Director at DiagnaMed Holdings Corp.
from 2023 to 2025.
Education includes an undergraduate degree from Toronto Metropolitan University, conferred in 2000.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
PHARMATHER HOLDINGS LTD 1,43 % | 16.07.2025 | 1.300.000 ( 1,43 % ) | 52 000 $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| PHARMATHER HOLDINGS LTD. | Direktor/Vorstandsmitglied | 01.06.2020 |
Sanscon Construction Ltd.
Sanscon Construction Ltd. Engineering & ConstructionIndustrial Services Provides engineering and construction services | Präsident | 01.01.1999 |
| Unternehmen | Position | Ende |
|---|---|---|
| DIAGNAMED HOLDINGS CORP. | Direktor/Vorstandsmitglied | 02.07.2025 |
| REVIVE THERAPEUTICS LTD. | Direktor/Vorstandsmitglied | 18.12.2019 |
Mercury Capital II Ltd.
Mercury Capital II Ltd. Financial ConglomeratesFinance Operates as a capital pool company | Direktor/Vorstandsmitglied | 08.01.2014 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Mercury Capital II Ltd.
Mercury Capital II Ltd. Financial ConglomeratesFinance Operates as a capital pool company | Finance |
Toronto Metropolitan University of
Toronto Metropolitan University of Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanscon Construction Ltd.
Sanscon Construction Ltd. Engineering & ConstructionIndustrial Services Provides engineering and construction services | Industrial Services |
Revive Therapeutics Ltd.
Revive Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Engages in acquiring, developing, and commercializing therapeutic products | Health Technology |
PharmaTher Holdings Ltd.
PharmaTher Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops psychedelic pharmaceuticals | Health Technology |
DiagnaMed Holdings Corp.
DiagnaMed Holdings Corp. BiotechnologyHealth Technology Engages in development and commercialization of digital therapeutics for people suffer from mental health and neurological disorders | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen